194 related articles for article (PubMed ID: 30135329)
1. Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.
Yagi S; Kondo D; Ise T; Fukuda D; Yamaguchi K; Wakatsuki T; Kawabata Y; Ito H; Saijo Y; Seno H; Sutou K; Ueno R; Todoroki T; Kusunose K; Matsuura T; Tobiume T; Yamada H; Soeki T; Shimabukuro M; Aihara KI; Akaike M; Sata M
J Atheroscler Thromb; 2019 Mar; 26(3):272-281. PubMed ID: 30135329
[TBL] [Abstract][Full Text] [Related]
2. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
[TBL] [Abstract][Full Text] [Related]
3. Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive Study.
Okada T; Miyoshi T; Doi M; Seiyama K; Takagi W; Sogo M; Nosaka K; Takahashi M; Okawa K; Ito H
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477264
[TBL] [Abstract][Full Text] [Related]
4. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
Arai K; Koba S; Yokota Y; Tsunoda F; Tsujita H; Kondo S; Tsukamoto S; Shoji M; Shinke T
J Atheroscler Thromb; 2020 Nov; 27(11):1216-1229. PubMed ID: 32595194
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with and ongoing use of omega-3 fatty acid ethyl esters reduce the slow-flow phenomenon and prevent in-stent restenosis in patients undergoing carotid artery stenting.
Nakagawa I; Park HS; Yokoyama S; Wada T; Yamada S; Motoyama Y; Kichikawa K; Nakase H
J Vasc Surg; 2017 Jul; 66(1):122-129. PubMed ID: 28359716
[TBL] [Abstract][Full Text] [Related]
6. Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome.
Yagi S; Aihara K; Fukuda D; Takashima A; Bando M; Hara T; Nishimoto S; Ise T; Kusunose K; Yamaguchi K; Tobiume T; Iwase T; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Akaike M; Sata M
Nutr J; 2015 Oct; 14():111. PubMed ID: 26514181
[TBL] [Abstract][Full Text] [Related]
7. Aberrant serum polyunsaturated fatty acids profile is relevant with acute coronary syndrome.
Sakamoto A; Saotome M; Hosoya N; Kageyama S; Yoshizaki T; Takeuchi R; Murata K; Nawada R; Onodera T; Takizawa A; Satoh H; Hayashi H
Heart Vessels; 2016 Aug; 31(8):1209-17. PubMed ID: 26233644
[TBL] [Abstract][Full Text] [Related]
8. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.
Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK
Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222
[TBL] [Abstract][Full Text] [Related]
9. Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Kita Y; Watanabe M; Kamon D; Ueda T; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Inoue F; Doi N; Okura H; Uemura S; Saito Y
J Am Heart Assoc; 2020 Aug; 9(16):e015593. PubMed ID: 32805184
[TBL] [Abstract][Full Text] [Related]
10. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
[TBL] [Abstract][Full Text] [Related]
11. Effect of Omega-3 Fatty Acids on Coronary Plaque Morphology - A Serial Computed Tomography Angiography Study.
Motoyama S; Nagahara Y; Sarai M; Kawai H; Miyajima K; Sato Y; Matsumoto R; Takahashi H; Naruse H; Ishii J; Ozaki Y; Izawa H
Circ J; 2022 Apr; 86(5):831-842. PubMed ID: 34776470
[TBL] [Abstract][Full Text] [Related]
12. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls.
Block RC; Harris WS; Reid KJ; Sands SA; Spertus JA
Atherosclerosis; 2008 Apr; 197(2):821-8. PubMed ID: 17875307
[TBL] [Abstract][Full Text] [Related]
13. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
[TBL] [Abstract][Full Text] [Related]
14. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study.
Nakao K; Noguchi T; Miura H; Asaumi Y; Morita Y; Takeuchi S; Matama H; Sawada K; Doi T; Hosoda H; Nakashima T; Honda S; Fujino M; Yoneda S; Kawakami S; Nagai T; Nishihira K; Kanaya T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Kusano K; Yamamoto H; Omae K; Ogawa H; Yasuda S
J Atheroscler Thromb; 2024 Feb; 31(2):122-134. PubMed ID: 37704431
[TBL] [Abstract][Full Text] [Related]
15. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Michishita I
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):320-6. PubMed ID: 23324995
[TBL] [Abstract][Full Text] [Related]
16. Low levels of serum n-3 polyunsaturated fatty acids are associated with worse heart failure-free survival in patients after acute myocardial infarction.
Hara M; Sakata Y; Nakatani D; Suna S; Usami M; Matsumoto S; Hamasaki T; Doi Y; Nishino M; Sato H; Kitamura T; Nanto S; Hori M; Komuro I;
Circ J; 2013; 77(1):153-62. PubMed ID: 23047296
[TBL] [Abstract][Full Text] [Related]
17. Association between the docosahexaenoic acid to arachidonic acid ratio and acute coronary syndrome: a multicenter observational study.
Nishizaki Y; Shimada K; Tani S; Ogawa T; Ando J; Takahashi M; Yamamoto M; Shinozaki T; Miyazaki T; Miyauchi K; Nagao K; Hirayama A; Yoshimura M; Komuro I; Nagai R; Daida H
BMC Cardiovasc Disord; 2016 Jul; 16(1):143. PubMed ID: 27387342
[TBL] [Abstract][Full Text] [Related]
18. Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease.
Kurisu S; Ishibashi K; Kato Y; Mitsuba N; Dohi Y; Nishioka K; Kihara Y
Heart Vessels; 2013 Jan; 28(1):34-8. PubMed ID: 22187148
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.
Zhu Y; Chen M; Liu K; Gao A; Kong X; Liu Y; Han H; Li H; Zhu H; Zhang J; Zhao Y
J Atheroscler Thromb; 2022 Aug; 29(8):1226-1235. PubMed ID: 34497172
[TBL] [Abstract][Full Text] [Related]
20. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
